Kintor Pharma completes first patient enrollment in long-term safety phase III trial of KX-826
The Long-term Safety Trial was approved to be conducted by China National Medical Products Administration (NMPA) on 18 April 2023
The Long-term Safety Trial was approved to be conducted by China National Medical Products Administration (NMPA) on 18 April 2023
KEYTRUDA plus concurrent chemoradiotherapy demonstrated statistically significant and clinically meaningful improvement in PFS versus concurrent chemoradiotherapy alone in these patients
Long COVID is a debilitating chronic condition that has affected over 100 million people globally
Chlorpromazine Hydrochloride Tablets USP had an estimated annual sale of USD 45 million in the U.S.
This product will be launched through Granules Consumer Health (GCH) division
Marketing Authorization replaces conditional Marketing Authorization and is first for Novavax in the EU
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
This four-day course is designed for professionals in the pharmaceutical, nutraceutical, and related industries
PrecisionLife to analyse OXEGENE data to improve mechanistic understanding of endometriosis and identify novel drug targets to support the development of new personalised treatments
This acquisition will significantly strengthen Croda’s Beauty Actives portfolio and increases its exposure to targeted prestige segments
Subscribe To Our Newsletter & Stay Updated